Filtros de búsqueda

Lista de obras de

A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation

scientific article published on 06 January 2021

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.

artículo científico publicado en 2014

Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy

artículo científico publicado en 2015

Correlation between BRAF mutational status and clinical response to pembrolizumab in advanced melanoma patients

artículo científico publicado en 2015

Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients.

artículo científico publicado en 2015

Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma

artículo científico publicado en 2017

Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology

artículo científico publicado en 2019

Do BRAF inhibitors select for populations with different disease progression kinetics?

artículo científico publicado en 2013

Efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg.

artículo científico publicado en 2014

Erratum to: Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

scholarly article published in Cancer Immunology, Immunotherapy

High expression of a spliced variant of FKBP51 in peripheral blood mononuclear cells of melanoma patients may be related to PDL-1 on tumour and predictive of response to Ipilimumab

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

article

MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab.

artículo científico publicado en 2014

Serious haematological toxicity during and after ipilimumab treatment: a case series.

artículo científico publicado en 2014

The abscopal effect: efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg

artículo científico publicado en 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda